RxDoctor Payments Data

Latisha Patterson, PA

Physician Assistant · Warrenton, NCNPI 1033460019

Payments from drug & device makers

$473in general payments, 2019–2025

Across 27 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$118
  • Abbott$72
  • Novo Nordisk$64
  • Amgen$32
  • Pfizer$29
  • Otsuka America Pharmaceutical, Inc.$26
  • plus $132 from 8 others

What the payments were for

  • Food & beverage$473100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$473 in reported general payments places this provider in the 55th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$27,443
Medicare patients
111
Services billed
554

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide43$70,048
JanuviaSitagliptin Phosphate30$29,283
EliquisApixaban31$27,597
Tresiba Flextouch U-200Insulin Degludec18$20,995
LinzessLinaclotide20$12,828
Soliqua 100-33Insulin Glargine/Lixisenatide14$11,980
MounjaroTirzepatide11$11,218
XareltoRivaroxaban11$8,953
VascepaIcosapent Ethyl11$3,655
SymbicortBudesonide/Formoterol Fumarate12$3,522
Lantus SolostarInsulin Glargine,hum.Rec.Anlog24$3,029
Novolog FlexpenInsulin Aspart18$2,345
Atorvastatin Calcium149$1,548
PaxlovidNirmatrelvir/Ritonavir12$1,365
Albuterol Sulfate HfaAlbuterol Sulfate38$1,025

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$64$70,04843 claims
PfizerEliquis, Paxlovid$29$28,96243 claims
AbbVieLinzess$14$12,82820 claims
Lilly USA, LLCMounjaro$118$11,21811 claims
AstraZenecaSymbicort$15$3,52212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Warrenton

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →